Spots Global Cancer Trial Database for hepatic artery infusion chemotherapy
Every month we try and update this database with for hepatic artery infusion chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | NCT03812770 | Hepatocellular ... | Sorafenib HAIC of FOLFOX HAIC of OXA | 18 Years - 75 Years | Sun Yat-sen University | |
| HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | NCT03780049 | Hepatocellular ... | HAIC of FOLFOX H101 Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| HAIC Versus Systemic Chemotherapy for Unresectable ICC | NCT03771846 | Intrahepatic Ch... | irinotecan, oxa... gemcitabine and... | 18 Years - 75 Years | Sun Yat-sen University | |
| Patient Outcomes After Hepatic Artery Infusion Pump Placement | NCT05468593 | Colorectal Live... Colorectal Canc... | 18 Years - | Mayo Clinic | ||
| Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy | NCT04994236 | Hepatocellular ... | Hepatic artery ... | 18 Years - 90 Years | Shanghai Zhongshan Hospital | |
| HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | NCT03812783 | Hepatocellular ... | Hepatic arteria... Folfox Protocol Sorafenib Hepatic arteria... FOLFIRINOX | 18 Years - 75 Years | Sun Yat-sen University | |
| HAIC Plus Lenvatinib and Toripalimab for Advanced HCC | NCT04044313 | Hepatocellular ... | Hepatic arteria... Lenvatinib Toripalimab | 18 Years - 75 Years | Sun Yat-sen University | |
| HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC | NCT03775395 | Hepatocellular ... | Lenvatinib Sorafenib Hepatic arteria... | 18 Years - 75 Years | Sun Yat-sen University | |
| Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy | NCT04994236 | Hepatocellular ... | Hepatic artery ... | 18 Years - 90 Years | Shanghai Zhongshan Hospital | |
| DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC | NCT06397235 | Hepatocellular ... | DEB-TACE+HAIC DEB-TACE | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC | NCT03775395 | Hepatocellular ... | Lenvatinib Sorafenib Hepatic arteria... | 18 Years - 75 Years | Sun Yat-sen University | |
| HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | NCT03780049 | Hepatocellular ... | HAIC of FOLFOX H101 Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | NCT04961970 | Intrahepatic Ch... | oxaliplatin , f... gemcitabine and... | 18 Years - 75 Years | Sun Yat-sen University | |
| Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | NCT03812770 | Hepatocellular ... | Sorafenib HAIC of FOLFOX HAIC of OXA | 18 Years - 75 Years | Sun Yat-sen University | |
| Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | NCT03812770 | Hepatocellular ... | Sorafenib HAIC of FOLFOX HAIC of OXA | 18 Years - 75 Years | Sun Yat-sen University | |
| DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC | NCT06397235 | Hepatocellular ... | DEB-TACE+HAIC DEB-TACE | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC | NCT06397235 | Hepatocellular ... | DEB-TACE+HAIC DEB-TACE | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC | NCT06041477 | Hepatocellular ... Chemotherapy Ef... Chemotherapeuti... | Oxaliplatin,cal... Concurrent Lenv... Concurrent PD-1... Sequential Lenv... Sequential PD-1... | 18 Years - 75 Years | Sun Yat-sen University | |
| HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure | NCT05233358 | Hepatocellular ... | Hepatic Artery ... Transarterial C... Regorafenib Immune Checkpoi... | 18 Years - 70 Years | The Central Hospital of Lishui City |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
